Literature DB >> 21195252

Killing two birds with one stone.

Gabriel Schembri1, Paul Schober.   

Abstract

Mesh：

Substances：

Year:  2011        PMID： 21195252     DOI： 10.1016/S0140-6736(10)61343-8

Source DB:  PubMed          Journal:  Lancet        ISSN： 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  9 in total

1.  Randomized clinical trial: Combination antiretroviral therapy with tenofovir-emtricitabine and lopinavir-ritonavir in patients with primary biliary cholangitis.

Authors:  Ellina Lytvyak; Ishwar Hosamani; Aldo J Montano-Loza; Lynora Saxinger; Andrew L Mason
Journal:  Can Liver J       Date:  2019-01-09

Review 2.  Combination antiretroviral studies for patients with primary biliary cirrhosis.

Authors:  Ellina Lytvyak; Aldo J Montano-Loza; Andrew L Mason
Journal:  World J Gastroenterol       Date:  2016-01-07       Impact factor: 5.742

3.  Single Topic Conference on Autoimmune Liver Disease from the Canadian Association for the Study of the Liver.

Authors:  Aldo J Montano-Loza; Jessica R Allegretti; Angela Cheung; Maryam Ebadi; David Jones; Nanda Kerkar; Cynthia Levy; Sumera Rizvi; John M Vierling; Fernando Alvarez; Wayne Bai; Susan Gilmour; Aliya Gulamhusein; Orlee Guttman; Bettina E Hansen; Sonya MacParland; Andrew Mason; Fernanda Onofrio; Pere Santamaria; Ashley Stueck; Mark Swain; Catherine Vincent; Amanda Ricciuto; Gideon Hirschfield
Journal:  Can Liver J       Date:  2021-11-11

4.  PBC: Animal Models of Cholangiopathies and Possible Endogenous Viral Infections.

Authors:  Masashi Ninomiya; Yoshiyuki Ueno; Tooru Shimosegawa
Journal:  Int J Hepatol       Date:  2011-08-08

5.  Role of novel retroviruses in chronic liver disease: assessing the link of human betaretrovirus with primary biliary cirrhosis.

Authors:  David Sharon; Andrew L Mason
Journal:  Curr Infect Dis Rep       Date:  2015-02       Impact factor: 3.725

Review 6.  Linking Human Betaretrovirus with Autoimmunity and Liver Disease in Patients with Primary Biliary Cholangitis.

Authors:  Hussain Syed; Tara Penner; Andrew L Mason
Journal:  Viruses       Date:  2022-08-31       Impact factor: 5.818

Review 7.  Is there a role for cyclophilin inhibitors in the management of primary biliary cirrhosis?

Authors:  Shawn T Wasilenko; Aldo J Montano-Loza; Andrew L Mason
Journal:  Viruses       Date:  2013-01-24       Impact factor: 5.048

8.  Impact of combination antiretroviral therapy in the NOD.c3c4 mouse model of autoimmune biliary disease.

Authors:  David Sharon; Min Chen; Guangzhi Zhang; Safwat Girgis; Banu Sis; Don Graham; Chelsea McDougall; Shawn T Wasilenko; Aldo Montano-Loza; Andrew L Mason
Journal:  Liver Int       Date:  2014-10-31       Impact factor: 5.828

Review 9.  Apples to Apples? A Comparison of Real-World Tolerability of Antiretrovirals in Patients with Human Immunodeficiency Virus Infection and Patients with Primary Biliary Cholangitis.

Authors:  Shannon L Turvey; Lynora Saxinger; Andrew L Mason
Journal:  Viruses       Date:  2022-03-03       Impact factor: 5.048
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.